Early Stage

Lipids for treatment of inflammatory skin diseases, cosmetic and pharmaceutical products based on solid science.


Raised to Date: Raised: $2,095

Total Commitments ($USD)



Start Date


Close Date


Min. Goal


Max. Goal


Min. Investment


Security Type

Equity - Common

Funding Type


Price Per Share


Pre-Money Valuation


Rolling Commitments ($USD)

Not Funded
Reporting Date


Days Remaining
Not Funded
% of Min. Goal


% of Max. Goal


Likelihood of Max
Not Funded
Avg. Daily Raise


Not Funded
Create a free account today to gain access to KingsCrowd analytics.

Corvallis, Oregon


Healthcare & Pharmaceuticals

Tech Sector

Lipidomics, Inc. is here with the solution for inflammatory skin diseases. They develop cosmetics and pharmaceutical products for dry and sensitive skin that help replenish liquids that are deficient in the skin barrier. Lipidomics scientific founders have been studying fundamental skin biology and dermatology for over two decades, and their studies have led them to create a topical application of two specific lipids that are effective for treating dry skin that can often be a precursor to eczema. Current treatments can suppress the immune response or have detrimental effects on skin health. Lipidomics’ product helps prevent that, allowing the integrity of the skin barrier to remain intact without triggering an immune response.
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Lipidomics on Netcapital
Platform: Netcapital
Security Type: Equity - Common
Valuation: $2,801,443

Follow company

Follow Lipidomics on Netcapital
View on Netcapital (Closed)